Unicorn India Ventures Strikes Gold: 6X Return from Cancer Care Innovator

Deep tech investor Unicorn India Ventures (UIV) is celebrating a win-win with a partial exit from Sascan Meditech, a Thiruvananthapuram-based healthcare innovator. This strategic move generated a whopping 6X return on their initial investment, showcasing UIV's keen eye for spotting promising deep tech ventures.

Early Backing for Affordable Cancer Care Solutions

UIV first invested in Sascan in 2020, recognizing the company's potential to revolutionize cancer care accessibility. Founded by Dr. Subhash Narayanan, a laser scientist passionate about Biophotonics, Sascan develops affordable healthcare solutions for cancer detection and treatment. Their flagship product, OralScan, is a portable, non-invasive device for early oral cancer screening, empowering healthcare workers in remote areas.

Unicorn India Ventures: Champions of Deep Tech and Rural Impact

"We actively seek deep tech business models with a social impact," says Anil Joshi, Managing Partner at UIV. "Investing beyond major cities to discover innovative solutions like Sascan's is a core part of our strategy." Dr. Narayanan's dedication to marrying technology with affordability for underserved communities resonated strongly with UIV's vision.

Continued Support for Sascan's Growth Trajectory

While partially exiting, UIV maintains a significant stake in Sascan, demonstrating their continued belief in the company's future. This strategic move also welcomes Time Medical Digital Health and Imaging Ventures as a new investor, further fueling Sascan's growth ambitions.

Sascan: Pioneering Affordable Diagnostics

Sascan's product portfolio includes not only OralScan but also CerviScan, designed to replace traditional digital colposcopy. Dr. Sushash Narayanan, Founder & CEO of Sascan, expresses his gratitude to UIV for their early support: "Having Unicorn India Ventures as our first institutional investor was a game-changer. Their belief and guidance have been instrumental in our journey."

With a new investor on board and ongoing product development, Sascan is poised to make a significant impact on global healthcare accessibility.

Unicorn India Ventures: A Track Record of Success

This impressive exit from Sascan further solidifies UIV's reputation as a leading early-stage venture capital firm. Their first fund, launched in 2016, boasts an impressive internal rate of return (IRR) exceeding 60% and stellar exits for investors.

Currently raising their third fund of Rs 1,000 crore, UIV remains focused on fostering innovation in areas like global SaaS, digital platforms, climate tech, and agritech. With their proven ability to identify and nurture promising ventures, Unicorn India Ventures is a force to be reckoned with in the Indian deep tech landscape.

Join Our Thriving Entrepreneurial Community

Follow TICE News on Social Media and create a strong community of Talent, Ideas, Capital, and Entrepreneurship. YouTube  | Linkedin | X (Twitter) | Facebook | News Letters